Spinal cord stimulators can significantly improve patients' lives. The province doesn't fund nearly enough of them, experts ...
Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose ...
In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback